This candidate vaccine is currently under evaluation in phase I clinical trials (Table 1)
Patients are typically advised to be vigilant about any new symptoms or changes in their health while on this medication, as early detection of side effects can lead to timely intervention
This approach is based on individual tolerance preference, not thyroid safety data, as there is no evidence that lower doses carry different thyroid risk profiles than standard doses
According to the articles summarized previously, the NTS and its projections to the LDTg, VTA, and NAc participate in the interactions between the GLP-1 pathway and alcohol/addictive drugs
Ready to start your journey
The most commonly reported side effects are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation